EMBECTA CORP. Increase (Decrease) in Accounts Payable and Accrued Liabilities
EMBECTA CORP. (EMBC) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-07
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $16.10M, a 387.88% increase year-over-year.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $8.80M.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$23.80M.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$11.70M, a 145.88% decline year-over-year.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$68.90M, a 214.83% decline from fiscal 2024.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $60.00M, a 659.49% increase from fiscal 2023.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $7.90M, a 89.73% decline from fiscal 2022.
- EMBECTA CORP. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $76.90M, a 91.29% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $24.90M derived: sum of 2 quarters · filed 2026-08-07 | $1.10M 10-Q · filed 2026-08-07 | -$10.60M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$15.00M 10-Q · filed 2026-05-05 | -$26.70M derived: sum of 3 quarters · filed 2026-05-05 | -$23.40M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | -$23.80M 10-Q · filed 2026-02-05 | -$35.50M derived: sum of 2 quarters · filed 2026-02-05 | -$32.20M derived: sum of 3 quarters · filed 2026-08-07 | -$51.90M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-09-30 | -$11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$8.40M derived: sum of 2 quarters · filed 2026-08-07 | -$28.10M derived: sum of 3 quarters · filed 2026-08-07 | -$68.90M 10-K · filed 2025-11-25 | ||
| 2025-06-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | -$16.40M derived: sum of 2 quarters · filed 2026-08-07 | -$57.20M 10-Q · filed 2026-08-07 | -$31.70M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | -$19.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | -$60.50M 10-Q · filed 2026-05-05 | -$35.00M derived: sum of 3 quarters · filed 2026-05-05 | -$900.00K derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$40.80M 10-Q · filed 2026-02-05 | -$15.30M derived: sum of 2 quarters · filed 2026-02-05 | $18.80M derived: sum of 3 quarters · filed 2026-02-05 | $34.90M derived: sum of 4 quarters · filed 2026-02-05 | ||
| 2024-09-30 | $25.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $59.60M derived: sum of 2 quarters · filed 2025-11-25 | $75.70M derived: sum of 3 quarters · filed 2025-11-25 | $60.00M 10-K · filed 2025-11-25 | ||
| 2024-06-30 | $34.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $50.20M derived: sum of 2 quarters · filed 2025-08-08 | $34.50M 10-Q · filed 2025-08-08 | -$10.90M derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2024-03-31 | $16.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $400.00K 10-Q · filed 2025-05-09 | -$45.00M derived: sum of 3 quarters · filed 2025-11-25 | -$11.40M derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2023-12-31 | -$15.70M 10-Q · filed 2025-02-06 | -$61.10M derived: sum of 2 quarters · filed 2025-11-25 | -$27.50M derived: sum of 3 quarters · filed 2025-11-25 | -$27.20M derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2023-09-30 | -$45.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$11.80M derived: sum of 2 quarters · filed 2025-11-25 | -$11.50M derived: sum of 3 quarters · filed 2025-11-25 | $7.90M 10-K · filed 2025-11-25 | ||
| 2023-06-30 | $33.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $33.90M derived: sum of 2 quarters · filed 2024-08-09 | $53.30M 10-Q · filed 2024-08-09 | $57.10M derived: sum of 4 quarters · filed 2024-12-11 | ||
| 2023-03-31 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $19.70M 10-Q · filed 2024-05-09 | $19.50M 10-Q · filed 2023-05-12 | $23.50M derived: sum of 3 quarters · filed 2024-12-11 | $111.90M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2022-12-31 | $19.40M 10-Q · filed 2024-02-09 | $23.20M derived: sum of 2 quarters · filed 2024-12-11 | $111.60M derived: sum of 3 quarters · filed 2024-12-11 | $98.80M derived: sum of 4 quarters · filed 2024-12-11 | ||
| 2022-09-30 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $92.20M derived: sum of 2 quarters · filed 2024-12-11 | $79.40M derived: sum of 3 quarters · filed 2024-12-11 | $76.90M 10-K · filed 2024-12-11 | $73.30M 10-K · filed 2022-12-22 | |
| 2022-06-30 | $88.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $75.60M derived: sum of 2 quarters · filed 2023-08-08 | $73.10M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$15.30M 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | -$2.50M 10-Q · filed 2023-02-14 | |||||
| 2021-09-30 | $40.20M 10-K · filed 2023-11-29 | $30.80M 10-K · filed 2022-12-22 | ||||
| 2020-09-30 | -$3.80M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |